⌘K

Login Start Free

Home/Filings/4/0000864268-03-000089

4//SEC Filing

BRADLEY PHARMACEUTICALS INC 4

Accession 0000864268-03-000089

CIK 0000864268operating

View on SEC.gov Company Profile

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 3:48 PM ET

Size

8.8 KB

Accession

0000864268-03-000089

Insider Transaction Report

Form 4

Period: 2003-09-10

BRADLEY PHARMACEUTICALS INCBDY

VP - Research and Development

Transactions

Discretionary Transaction
Stock Options (Right to buy)
2003-09-12$8.81/sh−1,877$16,536→ 0 total
Exercise: $8.81From: 2003-07-09Exp: 2004-07-08→ Common Stock (1,877 underlying)
Sale
Common Stock
2003-09-10$28.40/sh−1,877$53,307→ 2,226 total
Discretionary Transaction
Common Stock
2003-09-10$8.81/sh+1,877$16,536→ 4,103 total

Holdings

Stock Options (Right to buy)
Exercise: $10.58From: 2003-07-09Exp: 2006-07-08→ Common Stock (753 underlying)
753
Common Stock
(indirect: By IRA)
1,000
Common Stock
(indirect: By 401(k))
1,501
Stock Options (Right to buy)
Exercise: $1.09From: 2002-09-07Exp: 2009-09-06→ Common Stock (8,000 underlying)
8,000

Documents

1 file

4
c0001141757d20030915f4f.xmlPrimary
PRIMARY DOCUMENT

Issuer

BRADLEY PHARMACEUTICALS INC

CIK 0000864268

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000864268

Filing Metadata

Form type: 4
Filed: Sep 14, 8:00 PM ET
Accepted: Sep 15, 3:48 PM ET
Size: 8.8 KB

View on SEC.gov